Role of succinylation modification in central nervous system diseases
Ageing Research Reviews · 2024-03 · 95 · 102242
DOI: 10.1016/j.arr.2024.102242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024-03. Verfasst von Chao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, People's Republic of China. Hauptthemen laut MEDLINE: Lysine, Central Nervous System Diseases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Diseases of the central nervous system (CNS), including stroke, brain tumors, and neurodegenerative diseases, have a serious impact on human health worldwide, especially in elderly patients. The brain, which is one of the body's most metabolically dynamic organs, lacks fuel stores and therefore requires a continuous supply of energy substrates. Metabolic abnormalities are closely associated with the pathogenesis of CNS disorders. Post-translational modifications (PTMs) are essential regulatory mechanisms that affect the functions of almost all proteins. Succinylation, a broad-spectrum dynamic PTM, primarily occurs in mitochondria and plays a crucial regulatory role in various diseases. In addition to directly affecting various metabolic cycle pathways, succinylation serves as an efficient and rapid biological regulatory mechanism that establishes a connection between metabolism and proteins, thereby influencing cellular functions in CNS diseases. This review offers a comprehensive analysis of succinylation and its implications in the pathological mechanisms of CNS diseases. The objective is to outline novel strategies and targets for the prevention and treatment of CNS conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, People's Republic of China.
- Department of Cardiology, People's Hospital of Rizhao, Rizhao 276800, People's Republic of China.
- Qingdao University, Qingdao 266000, People's Republic of China.
- Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266000, People's Republic of China. Electronic address: yutao0112@qdu.edu.cn.
- Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, People's Republic of China. Electronic address: fengyugong@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Cui, W., Yu, B., Zhou, H., Cui, Z., Guo, P., Yu, T., & Feng, Y. (2024). Role of succinylation modification in central nervous system diseases. Ageing Research Reviews, 95, 102242. https://doi.org/10.1016/j.arr.2024.102242
Vancouver
Wang C, Cui W, Yu B, Zhou H, Cui Z, Guo P, et al. Role of succinylation modification in central nervous system diseases. Ageing Research Reviews. 2024;95:102242. doi:10.1016/j.arr.2024.102242
BibTeX
@article{Wang2024,
author = {Wang, Chao and Cui, Weigang and Yu, Bing and Zhou, Han and Cui, Zhenwen and Guo, Pin and Yu, Tao and Feng, Yugong},
title = {Role of succinylation modification in central nervous system diseases},
journal = {Ageing Research Reviews},
year = {2024},
volume = {95},
pages = {102242},
doi = {10.1016/j.arr.2024.102242}
}
EUVIMED